Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy
about
Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic PatientsCorrelating blood and urinary concentrations of clobazam doses in Japanese children and adolescents with intractable epilepsy.New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel.Pharmacogenomics in epilepsy.Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.PharmGKB summary: clobazam pathway, pharmacokinetics.
P2860
Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy
description
im Oktober 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 18 October 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2014
@uk
name
Effect of CYP2C19 polymorphism ...... apanese patients with epilepsy
@en
Effect of CYP2C19 polymorphism ...... apanese patients with epilepsy
@nl
type
label
Effect of CYP2C19 polymorphism ...... apanese patients with epilepsy
@en
Effect of CYP2C19 polymorphism ...... apanese patients with epilepsy
@nl
prefLabel
Effect of CYP2C19 polymorphism ...... apanese patients with epilepsy
@en
Effect of CYP2C19 polymorphism ...... apanese patients with epilepsy
@nl
P2093
P2860
P1476
Effect of CYP2C19 polymorphism ...... apanese patients with epilepsy
@en
P2093
Ikuko Yano
Kazuo Matsubara
Mai Shibata
Masako Kinoshita
Ryosuke Takahashi
Sachiyo Hashi
Satohiro Masuda
P2860
P2888
P356
10.1007/S00228-014-1773-Z
P577
2014-10-18T00:00:00Z